Patent 8940930 was granted and assigned to United Therapeutics on January, 2015 by the United States Patent and Trademark Office.
The present invention is directed to a novel method for preparing a synthetic intermediates for treprostinil. Also described are methods of preparing treprostinil comprising utilizing novel intermediates described herein as well as novel intermediates useful for synthesis prostacyclin derivatives, such as treprostinil.